|
|
Volumn 98, Issue 4, 2009, Pages 737-741
|
|
Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL;
ANTIDIABETIC AGENT;
CYCLOHEXANE DERIVATIVE;
DRUG DERIVATIVE;
GLIBENCLAMIDE;
INSULIN;
NATEGLINIDE;
PHENYLALANINE;
SULFONYLUREA DERIVATIVE;
CHEMISTRY;
DIABETES MELLITUS;
GENETICS;
HUMAN;
MUTATION;
NEWBORN;
ORAL DRUG ADMINISTRATION;
PHYSIOLOGY;
REVIEW;
SECRETION;
STIMULATION;
ADMINISTRATION, ORAL;
CYCLOHEXANES;
DIABETES MELLITUS;
GLYBURIDE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INFANT, NEWBORN;
INSULIN;
KATP CHANNELS;
MUTATION;
PHENYLALANINE;
STIMULATION, CHEMICAL;
SULFONYLUREA COMPOUNDS;
MLCS;
MLOWN;
|
|
EID: 66649098486
PISSN: 00215384
EISSN: None
Source Type: Journal
DOI: 10.2169/naika.98.737 Document Type: Review |
|
Times cited : (2)
|
|
References (10)
|
